Clinical Trials Browser

Phase 2 × Glioma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT02465268 2025-01-14

ATTAC-II

Phase 2 Completed

175 enrolled 18 charts

Glioblastoma, Glioma

NCT05366062 2022-05-13

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

Phase 2 Not yet recruiting

Glioma

NCT00458601 2018-01-16

ACT III

Phase 2 Completed

Glioma